Analysis of bone mineral density and bone turnover in the presence of polymethylmethacrylate particles
✍ Scribed by S. Zilber; S. W. Lee; R. L. Smith; S. Biswal; S. B. Goodman
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 194 KB
- Volume
- 90B
- Category
- Article
- ISSN
- 1552-4973
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Polymethylmethacrylate (PMMA) particles generated from joint arthroplasties appear to contribute to aseptic implant loosening through inflammation‐induced periprosthetic osteolysis. However, osteolysis appears to be multifactorial; whether a direct link exists between PMMA particles and osteolysis in vivo is unproven. With the aim to define the relationship between PMMA particles and osteolysis, the authors analyzed the bone mineral density, using microCT scans preoperatively, the first day postoperatively and then every 7–10 days for 32 days, and bone turnover, using ^18^F‐fluoride positron emission tomography scanner (PET scan) at 8 weeks in four groups of mice that had undergone intramedullary femoral injection. The experimental group of five mice was injected with PMMA particles, and compared with two negative control groups (no injection and injection with the carrier, phosphate‐buffered saline) and one positive control group (injection of PMMA particles contaminated with endotoxin). There was no significant change in bone mineral density with addition of PMMA particles, and no evidence of osteolysis. However, bone turnover was increased in the presence of PMMA particles. Even though a direct link between PMMA particles and osteolysis was not found in the short term, PMMA particles appear to influence the regenerative capacity of bone. © 2008 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2009
📜 SIMILAR VOLUMES
## Abstract This randomized, double‐blind, placebo‐controlled, dose‐response late phase 2 study evaluated the efficacy and safety of bazedoxifene in postmenopausal Japanese women 85 years of age or younger with osteoporosis. Eligible subjects received daily treatment with oral doses of bazedoxifene
## Abstract ## Purpose: To apply pharmacokinetic modeling to the investigation of bone perfusion in subjects of varying bone mineral density. ## Materials and Methods: This study re‐analyzed previous experimental data. A modified pharmacokinetic model was applied to data obtained from two prior
## Abstract The aim of this study was to determine if single‐nucleotide polymorphisms (SNPs) in __RANKL__, __RANK__, and __OPG__ influence bone turnover and bone mineral density (BMD) in men. Pairwise tag SNPs (__r__^2^ ≥ 0.8) were selected for __RANKL__, __RANK__, and __OPG__ and their 10‐kb flank